Canagliflozin and the Incidence of Diabetic Ketoacidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
Diabetes Care 2015 Jul 22;[EPub Ahead of Print], N Erondu, M Desai, K Ways, G MeiningerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.